Gu W - Search Results

1

Undo the brake of tumour immune tolerance with antibodies, peptide mimetics and small molecule compounds targeting PD-1/PD-L1 checkpoint at different locations for acceleration of cytotoxic immunity to cancer cells.

Gu W, Wang L, Wu Y, Liu JP. Gu W, et al. Clin Exp Pharmacol Physiol. 2019 Feb;46(2):105-115. doi: 10.1111/1440-1681.13056. Clin Exp Pharmacol Physiol. 2019. PMID: 30565707 Review.

2

ATP-binding cassette transporter A1 (ABCA1) promotes arsenic tolerance in human cells by reducing cellular arsenic accumulation.

Tan X, Yang L, Xian L, Huang J, Di C, Gu W, Guo S, Yang L. Tan X, et al. Among authors: gu w. Clin Exp Pharmacol Physiol. 2014 Apr;41(4):287-94. doi: 10.1111/1440-1681.12219. Clin Exp Pharmacol Physiol. 2014. PMID: 24552478

3

PI3K/Akt/mTOR pathway dual inhibitor BEZ235 suppresses the stemness of colon cancer stem cells.

Chen J, Shao R, Li F, Monteiro M, Liu JP, Xu ZP, Gu W. Chen J, et al. Among authors: gu w. Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1317-26. doi: 10.1111/1440-1681.12493. Clin Exp Pharmacol Physiol. 2015. PMID: 26399781

4

Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia-inducible factors HIF1α and HIF2α.

Schöning JP, Monteiro M, Gu W. Schöning JP, et al. Among authors: gu w. Clin Exp Pharmacol Physiol. 2017 Feb;44(2):153-161. doi: 10.1111/1440-1681.12693. Clin Exp Pharmacol Physiol. 2017. PMID: 27809360 Review.

5

Increased PD-L1 expression in breast and colon cancer stem cells.

Wu Y, Chen M, Wu P, Chen C, Xu ZP, Gu W. Wu Y, et al. Among authors: gu w. Clin Exp Pharmacol Physiol. 2017 May;44(5):602-604. doi: 10.1111/1440-1681.12732. Clin Exp Pharmacol Physiol. 2017. PMID: 28107571

6

Laser capture microdissection for detecting the expression of epithelial-mesenchymal transition-related genes in epithelial and spindle cells of paraffin-embedded formalin-fixed biphasic synovial sarcoma.

Wang N, Liu ZH, Zou H, Pang LJ, Gu WY, Hu JM, Li DM, Zhao J, Zhang J, Liu CX, Zhang WJ, Qi Y, Li F. Wang N, et al. Clin Exp Pharmacol Physiol. 2018 Jul;45(7):675-682. doi: 10.1111/1440-1681.12936. Epub 2018 Apr 30. Clin Exp Pharmacol Physiol. 2018. PMID: 29575169

7

Optimization of Formulations Consisting of Layered Double Hydroxide Nanoparticles and Small Interfering RNA for Efficient Knockdown of the Target Gene.

Wu Y, Gu W, Chen C, Do ST, Xu ZP. Wu Y, et al. Among authors: gu w. ACS Omega. 2018 May 31;3(5):4871-4877. doi: 10.1021/acsomega.8b00397. Epub 2018 May 2. ACS Omega. 2018. PMID: 30023905 Free PMC article.

8

Enhancing PD-1 Gene Silence in T Lymphocytes by Comparing the Delivery Performance of Two Inorganic Nanoparticle Platforms.

Wu Y, Gu W, Li L, Chen C, Xu ZP. Wu Y, et al. Among authors: gu w. Nanomaterials (Basel). 2019 Jan 28;9(2):159. doi: 10.3390/nano9020159. Nanomaterials (Basel). 2019. PMID: 30696033 Free PMC article.

9

Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells.

Chen M, Sharma A, Lin Y, Wu Y, He Q, Gu Y, Xu ZP, Monteiro M, Gu W. Chen M, et al. Among authors: gu w, gu y. BMC Cancer. 2019 Feb 15;19(1):153. doi: 10.1186/s12885-019-5364-3. BMC Cancer. 2019. PMID: 30770752 Free PMC article.

10

Silencing PD-1 and PD-L1 with nanoparticle-delivered small interfering RNA increases cytotoxicity of tumor-infiltrating lymphocytes.

Wu Y, Gu W, Li J, Chen C, Xu ZP. Wu Y, et al. Among authors: gu w. Nanomedicine (Lond). 2019 Apr;14(8):955-967. doi: 10.2217/nnm-2018-0237. Epub 2019 Mar 22. Nanomedicine (Lond). 2019. PMID: 30901292 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,218 results

Search Page

Filters